U.S. patents available from 1976 to present.
U.S. patent applications available from 2005 to present.

Device for pH independent release of drugs through the Donnan-like influence of charged insoluble resins

Patent 4795644 Issued on January 3, 1989. Estimated Expiration Date: Icon_subject August 3, 2007. Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.

Patent References

2846057

2928770

3538214

Coating compositions for solid medicines
Patent #: 3957523
Issued on: 05/18/1976
Inventor: Ohno ,   et al.

Microporous drug delivery device
Patent #: 3993072
Issued on: 11/23/1976
Inventor: Zaffaroni

Osmotic system having laminated wall comprising semipermeable lamina and microporous lamina
Patent #: 4160452
Issued on: 07/10/1979
Inventor: Theeuwes

Osmotic system with distribution zone for dispensing beneficial agent
Patent #: 4200098
Issued on: 04/29/1980
Inventor: Ayer ,   et al.

System with microporous reservoir having surface for diffusional delivery of agent
Patent #: 4217898
Issued on: 08/19/1980
Inventor: Theeuwes

Prolonged release pharmaceutical preparations
Patent #: 4221778
Issued on: 09/09/1980
Inventor: Raghunathan

Device for dispensing drug by combined diffusional and osmotic operations
Patent #: 4235236
Issued on: 11/25/1980
Inventor: Theeuwes

More ...

Inventor

Assignee

Application

No. 07/081090 filed on 08/03/1987

US Classes:

424/468, Sustained or differential release type424/457, Sustained or differential release424/474, Coated pills or tablets424/482Containing solid synthetic polymers

Examiners

Primary: Page, Thurman K.
Assistant: Horne, Leon R.

Attorney, Agent or Firm

International Class

A61K 9/00 (20060101)

Abstract

A device is disclosed for the controlled delivery of a beneficial agent. The agent is delivered to the environment surrounding the device at a substantially constant rate for a specified period with a reduced dependence on the environmental pH. The device is comprised of a core compartment containing (1) a charged, water insoluble, non-diffusible component and (2) at least one diffusable water soluble ionizable beneficial agent. The core is surrounded by a water insoluble wall containing leachable pore forming additive(s) dispersed throughout said wall, with said wall impermeable to core components (1) and permeable to beneficial agent(s) (2). In operation the insoluble charged component (often polymeric resins) and water soluble ionizable beneficial agent have the same electro-static charge and do not form an ion exchange complex. Rather, a Donnan influenced mass transport phenomena of the beneficial agent is effected through the pores in the device, actuated by water from the environment, with migration of the freely mobile diffusible species (beneficial agent) away from the non-mobile species (charged entity). This effects the release of the beneficial agent through the wall at a controlled rate with reduced pH dependency.

Other References

  • J Pharm. Sci., 72, pp. 772-775
PatentsPlus Images
Enhanced PDF formats
loading...
PatentsPlus: add to cart
PatentsPlus: add to cartSearch-enhanced full patent PDF image
$9.95more info
PatentsPlus: add to cart
PatentsPlus: add to cartIntelligent turbocharged patent PDFs with marked up images
$18.95more info
 
Sign InRegister
Username  
Password   
forgot password?